UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Annals of oncology, 2017-02, Vol.28 (2), p.339-343

2017

Link zum Volltext

Verfügbarkeit prüfen

Piecewise Modeling Of Time-To-Event Data With Flexible Parameterization Of Covariates And Effects

Value in health, 2013-05, Vol.16 (3), p.A2-A2

Ishak, K.J

2013

Link zum Volltext

Verfügbarkeit prüfen

A Statistical Modeling Framework To Characterize the Impact of Progression on Survival in Oncology

Value in health, 2014-11, Vol.17 (7), p.A583-A583

Ishak, K.J

2014

Link zum Volltext

Verfügbarkeit prüfen

Quantifying the impact of progression on survival in oncology: An application of statistical modeling framework to measure the impact of events on subsequent risks

Value in health, 2014-05, Vol.17 (3), p.A206-A206

2014

Link zum Volltext

Verfügbarkeit prüfen

IMPROVING PRECISION BY APPLYING DISEASE PROGRESSION EQUATIONS FROM MULTIPLE SOURCES IN THE ALZHEIMER’S DISEASE ARCHIMEDES CONDITION EVENT (ACE) SIMULATOR

Value in health, 2016-05, Vol.19 (3), p.A85-A85

2016

Link zum Volltext

Verfügbarkeit prüfen

PNS26 USING SURROGATES FOR PREDICTION OVERALL SURVIVAL IN ONCOLOGY: CONSIDERATIONS FOR NEW TREATMENTS AND EARLIER STAGES OF CANCER

Value in health, 2019-11, Vol.22, p.S767-S767

2019

Link zum Volltext

Verfügbarkeit prüfen

Important Statistical Considerations For Developing Equations For Disease Simulators

Value in health, 2015-05, Vol.18 (3), p.A35-A35

2015

Link zum Volltext

Verfügbarkeit prüfen

Simulated Treatment Comparisons – An Alternative Approach to Indirect Comparison When Standard Methods Are Not Feasible or Appropriate

Value in health, 2013-11, Vol.16 (7), p.A615-A615

2013

Link zum Volltext

Verfügbarkeit prüfen

Considerations In The Appplication Of Novel Statistical Methods For Crossover Adjustment In Trials Of Cancer Treatments

Value in health, 2013-05, Vol.16 (3), p.A54-A54

2013

Link zum Volltext

Verfügbarkeit prüfen

SA48 Comparative Effectiveness Based on Win Ratios: Do Conventional ITC Approaches Work?

Value in health, 2023-12, Vol.26 (12), p.S550

2023

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Groundbreaking Medical Therapy on the Incidence of Disease: A Case Study of Rituximab and Non-Hodgkin’s Lymphoma

Value in health, 2014-05, Vol.17 (3), p.A71-A71

2014

Link zum Volltext

Verfügbarkeit prüfen

PRM230 - A Statistical Modeling Framework To Characterize the Impact of Progression on Survival in Oncology

Value in health, 2014-11, Vol.17 (7), p.A583-A583

Ishak, K.J.

2014

Link zum Volltext

Verfügbarkeit prüfen

MSR77 Can Bayesian Informative Priors Improve Extrapolation of Immature Overall Survival? A Case Study in Advanced Melanoma

Value in health, 2023-12, Vol.26 (12), p.S407

2023

Link zum Volltext

Verfügbarkeit prüfen

SA72 Current Practices for the Selection of Effect Modifiers and Confounders in Population-Adjusted Indirect Comparisons (PAIC): A Review of Technology Appraisals (TA)

Value in health, 2023-12, Vol.26 (12), p.S555

2023

Link zum Volltext

Verfügbarkeit prüfen

PRM48 DESIGN AND OPERATIONAL CONSIDERATIONS FOR PRAGMATIC CLINICAL TRIALS TO SUPPORT HEOR EVALUATIONS

Value in health, 2011, Vol.14 (3), p.A154-A154

2011

Link zum Volltext

Verfügbarkeit prüfen

CP3 - Piecewise Modeling Of Time-To-Event Data With Flexible Parameterization Of Covariates And Effects

Value in health, 2013-05, Vol.16 (3), p.A2-A2

Ishak, K.J.

2013

Link zum Volltext

Verfügbarkeit prüfen

PNS22 USING TWITTER TO HARVEST DATA FROM SCIENTIFIC CONFERENCES:A PROOF OF CONCEPT OF A NEW APPROACH TO RETRIEVE CLINICAL TRIAL RESULTS

Value in health, 2019-11, Vol.22, p.S766-S766

2019

Link zum Volltext

Verfügbarkeit prüfen

PRM146 - Quantifying the impact of progression on survival in oncology: An application of statistical modeling framework to measure the impact of events on subsequent risks

Value in health, 2014-05, Vol.17 (3), p.A206-A206

2014

Link zum Volltext

Verfügbarkeit prüfen

PRS45 MODELING THE IMPACT OF MULTIPLE QUIT ATTEMPTS IN SMOKERS USING DISCRETE EVENT SIMULATION (DES)

Value in health, 2011, Vol.14 (3), p.A145-A145

2011

Link zum Volltext

Verfügbarkeit prüfen

PCP54 - OVERVIEW OF METHODS FOR ASSESSING COMPARATIVE EVIDENCE FOR TREATMENTS EVALUATED IN EARLY PHASE TRIALS IN ONCOLOGY

Value in health, 2018-10, Vol.21, p.S90-S90

2018

Link zum Volltext

Verfügbarkeit prüfen

PCP45 - THE ROLE OF CROSSOVER AND TREATMENT SWITCHING IN INDIRECT TREATMENT COMPARSON IN IMMUNO-ONCOLOGY

Value in health, 2018-10, Vol.21, p.S88-S88

2018

Link zum Volltext

Verfügbarkeit prüfen

PRM80 - IMPROVING PRECISION BY APPLYING DISEASE PROGRESSION EQUATIONS FROM MULTIPLE SOURCES IN THE ALZHEIMER’S DISEASE ARCHIMEDES CONDITION EVENT (ACE) SIMULATOR

Value in health, 2016-05, Vol.19 (3), p.A85-A85

2016

Link zum Volltext

Verfügbarkeit prüfen

PRM143 - Important Statistical Considerations For Developing Equations For Disease Simulators

Value in health, 2015-05, Vol.18 (3), p.A35-A35

2015

Link zum Volltext

Verfügbarkeit prüfen

PRM228 - Simulated Treatment Comparisons – An Alternative Approach to Indirect Comparison When Standard Methods Are Not Feasible or Appropriate

Value in health, 2013-11, Vol.16 (7), p.A615-A615

2013

Link zum Volltext

Verfügbarkeit prüfen

PRM227 - Considerations In The Appplication Of Novel Statistical Methods For Crossover Adjustment In Trials Of Cancer Treatments

Value in health, 2013-05, Vol.16 (3), p.A54-A54

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Piecewise Modeling Of Time-To-Event Data With Flexible Parameterization Of Covariates And Effects

A Statistical Modeling Framework To Characterize the Impact of Progression on Survival in Oncology

Quantifying the impact of progression on survival in oncology: An application of statistical modeling framework to measure the impact of events on subsequent risks

IMPROVING PRECISION BY APPLYING DISEASE PROGRESSION EQUATIONS FROM MULTIPLE SOURCES IN THE ALZHEIMER’S DISEASE ARCHIMEDES CONDITION EVENT (ACE) SIMULATOR

PNS26 USING SURROGATES FOR PREDICTION OVERALL SURVIVAL IN ONCOLOGY: CONSIDERATIONS FOR NEW TREATMENTS AND EARLIER STAGES OF CANCER

Important Statistical Considerations For Developing Equations For Disease Simulators

Simulated Treatment Comparisons – An Alternative Approach to Indirect Comparison When Standard Methods Are Not Feasible or Appropriate

Considerations In The Appplication Of Novel Statistical Methods For Crossover Adjustment In Trials Of Cancer Treatments

SA48 Comparative Effectiveness Based on Win Ratios: Do Conventional ITC Approaches Work?

The Effect of Groundbreaking Medical Therapy on the Incidence of Disease: A Case Study of Rituximab and Non-Hodgkin’s Lymphoma

PRM230 - A Statistical Modeling Framework To Characterize the Impact of Progression on Survival in Oncology

MSR77 Can Bayesian Informative Priors Improve Extrapolation of Immature Overall Survival? A Case Study in Advanced Melanoma

SA72 Current Practices for the Selection of Effect Modifiers and Confounders in Population-Adjusted Indirect Comparisons (PAIC): A Review of Technology Appraisals (TA)

PRM48 DESIGN AND OPERATIONAL CONSIDERATIONS FOR PRAGMATIC CLINICAL TRIALS TO SUPPORT HEOR EVALUATIONS

CP3 - Piecewise Modeling Of Time-To-Event Data With Flexible Parameterization Of Covariates And Effects

PNS22 USING TWITTER TO HARVEST DATA FROM SCIENTIFIC CONFERENCES:A PROOF OF CONCEPT OF A NEW APPROACH TO RETRIEVE CLINICAL TRIAL RESULTS

PRM146 - Quantifying the impact of progression on survival in oncology: An application of statistical modeling framework to measure the impact of events on subsequent risks

PRS45 MODELING THE IMPACT OF MULTIPLE QUIT ATTEMPTS IN SMOKERS USING DISCRETE EVENT SIMULATION (DES)

PCP54 - OVERVIEW OF METHODS FOR ASSESSING COMPARATIVE EVIDENCE FOR TREATMENTS EVALUATED IN EARLY PHASE TRIALS IN ONCOLOGY

PCP45 - THE ROLE OF CROSSOVER AND TREATMENT SWITCHING IN INDIRECT TREATMENT COMPARSON IN IMMUNO-ONCOLOGY

PRM80 - IMPROVING PRECISION BY APPLYING DISEASE PROGRESSION EQUATIONS FROM MULTIPLE SOURCES IN THE ALZHEIMER’S DISEASE ARCHIMEDES CONDITION EVENT (ACE) SIMULATOR

PRM143 - Important Statistical Considerations For Developing Equations For Disease Simulators

PRM228 - Simulated Treatment Comparisons – An Alternative Approach to Indirect Comparison When Standard Methods Are Not Feasible or Appropriate

PRM227 - Considerations In The Appplication Of Novel Statistical Methods For Crossover Adjustment In Trials Of Cancer Treatments

Suchergebnisse filtern